Nicholson Brian D, Mant David, Neal Richard D, Hart Nigel, Hamilton Willie, Shinkins Bethany, Rubin Greg, Rose Peter W
University of Oxford, Oxford.
Bangor University, Bangor.
Br J Gen Pract. 2016 Feb;66(643):e106-13. doi: 10.3399/bjgp16X683449. Epub 2016 Jan 6.
Variation in cancer survival persists between comparable nations and appears to be due, in part, to primary care practitioners (PCPs) having different thresholds for acting definitively in response to cancer-related symptoms.
To explore whether cancer guidelines, and adherence to them, differ between jurisdictions and impacts on PCPs' propensity to take definitive action on cancer-related symptoms.
A secondary analysis of survey data from six countries (10 jurisdictions) participating in the International Cancer Benchmarking Partnership.
PCPs' responses to five clinical vignettes presenting symptoms and signs of lung (n = 2), colorectal (n = 2), and ovarian cancer (n = 1) were compared with investigation and referral recommendations in cancer guidelines.
Nine jurisdictions had guidelines covering the two colorectal vignettes. For the lung vignettes, although eight jurisdictions had guidelines for the first, the second was covered by a Swedish guideline alone. Only the UK and Denmark had an ovarian cancer guideline. Survey responses of 2795 PCPs (crude response rate: 12%) were analysed. Guideline adherence ranged from 20-82%. UK adherence was lower than other jurisdictions for the lung vignette covered by the guidance (47% versus 58%; P <0.01) but similar (45% versus 46%) or higher (67% versus 38%; P <0.01) for the two colorectal vignettes. PCPs took definitive action least often when a guideline recommended a non-definitive action or made no recommendation. UK PCPs adhered to recommendations for definitive action less than their counterparts (P <0.01). There wasno association between jurisdictional guideline adherence and 1-year survival.
Cancer guideline content is variable between similarly developed nations and poor guideline adherence does not explain differential survival. Guidelines that fail to cover high-risk presentations or that recommend non-definitive action may reduce definitive diagnostic action.
在可比国家之间,癌症生存率存在差异,部分原因似乎是初级保健医生(PCP)对癌症相关症状采取明确行动的阈值不同。
探讨不同司法管辖区的癌症指南及其遵循情况是否存在差异,以及对初级保健医生针对癌症相关症状采取明确行动倾向的影响。
对参与国际癌症基准伙伴关系的六个国家(10个司法管辖区)的调查数据进行二次分析。
将初级保健医生对五个呈现肺癌(n = 2)、结直肠癌(n = 2)和卵巢癌(n = 1)症状和体征的临床案例的反应,与癌症指南中的检查和转诊建议进行比较。
九个司法管辖区有涵盖两个结直肠癌案例的指南。对于肺癌案例,虽然八个司法管辖区有第一个案例的指南,但第二个案例仅由瑞典指南涵盖。只有英国和丹麦有卵巢癌指南。分析了2795名初级保健医生的调查回复(粗略回复率:12%)。指南遵循率在20%至82%之间。对于指南涵盖的肺癌案例,英国的遵循率低于其他司法管辖区(47%对58%;P <0.01),但对于两个结直肠癌案例,英国的遵循率相似(45%对46%)或更高(67%对38%;P <0.01)。当指南建议采取非明确行动或未给出建议时,初级保健医生采取明确行动的频率最低。英国初级保健医生对明确行动建议的遵循率低于其他国家同行(P <0.01)。司法管辖区的指南遵循情况与1年生存率之间没有关联。
在发展程度相似的国家之间,癌症指南内容存在差异,指南遵循情况不佳并不能解释生存率的差异。未能涵盖高风险表现或建议采取非明确行动的指南可能会减少明确的诊断行动。